CD8A and neoplasm: Using the TCR as a “molecular barcode,” we used paired tumor and blood samples to identify and characterize tumor-matching (TM) blood CD8+ T cells that had shared TCR sequences with CD8+ T cells in MC38 tumors in mice or melanoma in patients.